1. Home
  2. ATNM vs HPH Comparison

ATNM vs HPH Comparison

Compare ATNM & HPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ATNM
  • HPH
  • Stock Information
  • Founded
  • ATNM 2000
  • HPH 2010
  • Country
  • ATNM United States
  • HPH China
  • Employees
  • ATNM N/A
  • HPH N/A
  • Industry
  • ATNM Biotechnology: Pharmaceutical Preparations
  • HPH
  • Sector
  • ATNM Health Care
  • HPH
  • Exchange
  • ATNM Nasdaq
  • HPH NYSE
  • Market Cap
  • ATNM 46.5M
  • HPH 50.5M
  • IPO Year
  • ATNM N/A
  • HPH 2019
  • Fundamental
  • Price
  • ATNM $1.61
  • HPH $0.15
  • Analyst Decision
  • ATNM Strong Buy
  • HPH
  • Analyst Count
  • ATNM 4
  • HPH 0
  • Target Price
  • ATNM $8.75
  • HPH N/A
  • AVG Volume (30 Days)
  • ATNM 1.3M
  • HPH 821.7K
  • Earning Date
  • ATNM 04-25-2025
  • HPH 01-01-0001
  • Dividend Yield
  • ATNM N/A
  • HPH N/A
  • EPS Growth
  • ATNM N/A
  • HPH N/A
  • EPS
  • ATNM N/A
  • HPH N/A
  • Revenue
  • ATNM $81,000.00
  • HPH $286,996,105.00
  • Revenue This Year
  • ATNM $138.42
  • HPH N/A
  • Revenue Next Year
  • ATNM $16,957.05
  • HPH N/A
  • P/E Ratio
  • ATNM N/A
  • HPH N/A
  • Revenue Growth
  • ATNM N/A
  • HPH 1722.41
  • 52 Week Low
  • ATNM $1.03
  • HPH $0.13
  • 52 Week High
  • ATNM $10.24
  • HPH $9.50
  • Technical
  • Relative Strength Index (RSI)
  • ATNM 59.52
  • HPH 39.48
  • Support Level
  • ATNM $1.66
  • HPH $0.14
  • Resistance Level
  • ATNM $2.41
  • HPH $0.16
  • Average True Range (ATR)
  • ATNM 0.22
  • HPH 0.02
  • MACD
  • ATNM 0.05
  • HPH 0.00
  • Stochastic Oscillator
  • ATNM 37.60
  • HPH 18.00

About ATNM Actinium Pharmaceuticals Inc. (Delaware)

Actinium Pharmaceuticals Inc is a biopharmaceutical company engaged in the development of radiotherapies for patients with cancers lacking effective treatment options. The company's proprietary technology platform utilizes monoclonal antibodies to deliver radioisotopes directly to cells of interest to kill those cells safely and effectively. Its product candidates are Iomab-B, an antibody-drug construct containing iodine 131 (I-131), used for hematopoietic stem cells transplantation in various indications and Actimab-A, an antibody-drug construct containing actinium 225 (Ac-225), currently in human clinical trials for acute myeloid leukemia.

About HPH HIGHEST PERFORMANCE HLDGS INC

Highest Performances Holdings Inc is a financial technology service group based on family financial asset allocation. The Group operate theree segments: (1) the insurance agency segment, which mainly consists of providing agency services for a wide range of life and non-life insurance products to individual clients, (2) the claims adjusting segment, which consists of providing pre-underwriting survey services, claim adjusting services, disposal of residual value services, loading and unloading supervision services, and consulting services, and (3) the wealth management segment, which mainly consists of providing distribution and managing wealth management services. Maximum revenue is from The Insurance Agency Segment.

Share on Social Networks: